Re: doctors overprescribe costly cholesterol-lowering drugs for minimal benefits
- From: Roger Rabbit <rogers@xxxxxxxx>
- Date: Thu, 14 Apr 2005 17:54:01 -0400
Nobody ever accused the health system of practicing preventative
medicine. ;o)
rr
On Tue, 12 Apr 2005 11:25:56 -0700, "Robert" <RobertJ@xxxxxxxxxxx>
wrote:
>
>"montygram" <nazztrader@xxxxxxxxx> wrote in message
>news:1113329011.205127.165860@xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
>> Old news. Read the book, Heart Failure, and you'll see what I mean.
>
>Canada is doing an excellent job of saving money.
>They have a good idea in that they should wait for somebody to get heart
>disease before doing anything. It is much more cost effective.
>That eliminates all the guess work in using predictive risk factors. You
>just wait for them to get it. It is 100% sensitive and 100% specific in
>picking up heart disease. Wait for them to get it.
>The billions of dollars used in preventing disease are better spent with
>treating disease.
>>
>>
>> TC wrote:
>> >
>> http://www.cbc.ca/story/science/national/2005/04/11/statins050411.html
>> >
>> > Improve cholesterol drug prescribing habits, medical team advises
>> > Last Updated Mon, 11 Apr 2005 22:07:11 EDT
>> > CBC News
>> > TORONTO - Current Canadian guidelines are leading doctors to
>> > overprescribe costly cholesterol-lowering drugs for minimal benefits,
>> > one group of researchers says.
>> >
>> > A high cholesterol level is one of the factors physicians use to
>> assess
>> > someone's risk of having a heart attack, along with age, smoking and
>> > blood pressure, among others.
>> >
>> > In 2003, Canadian doctors wrote more than 15 million prescriptions
>> for
>> > statins.
>> >
>> > In 2003, a special advisory group issued guidelines that recommended
>> > more people be considered at risk of dying from heart disease, and
>> > therefore treated with statins like Lipitor if changes in diet and
>> > exercise don't help.
>> >
>> > Now a group of researchers at Toronto's Institute for Clinical
>> > Evaluative Sciences, or ICES, say the guidelines should be revised.
>> The
>> > non-profit group uses population-based information to add knowledge
>> on
>> > a broad range of health-care issues.
>> >
>> > Dr. Douglas Manuel and his team contend the guidelines could see
>> > 500,000 more Canadians on medication, at a cost of millions of
>> dollars,
>> > while saving few lives in the long run.
>> >
>> > "If you're young and you're generally healthy, your risk of having a
>> > heart attack is going to be low no matter what your cholesterol level
>> > is," said Manuel, one of the authors of the study in Tuesday's issue
>> of
>> > the Canadian Medical Association Journal.
>> >
>> > The ICES team looked at Canadians aged 18 to 74 between 1988 and 1992
>> > who were considered at low risk for heart disease but who qualify for
>> > statin therapy under current guidelines. Their goal was to run a
>> > reality check, estimating how many such people would need to take the
>> > drugs to save one life.
>> >
>> > They concluded 19,600 people would have to take the medication for
>> five
>> > years to prevent a single death from heart disease. Potential
>> > side-effects of statins include muscle pain and liver problems.
>> >
>> > Statins already cost Canada's health-care system $1.6 billion per
>> year,
>> > according to IMS Health, a company that tracks prescription drug
>> sales.
>> >
>> >
>> > By tweaking the guidelines to treat everyone at high risk while
>> > de-emphasizing treatment for those at low risk, hundreds of millions
>> of
>> > dollars could be saved while potentially avoiding 1,000 more deaths
>> > from heart disease over five years, Manuel said.
>> >
>> > Current guidelines also fail to recommend statin treatment for 13 per
>> > cent of the highest risk Canadians, the team said.
>> >
>> > Cardiologist Dr. Jacques Genest of Montreal's Royal Victoria
>> Hospital,
>> > who helped write the cholesterol treatment guidelines, said there are
>> > flaws in the ICES study.
>> >
>> > "They based their assumption of cholesterol reduction on very old
>> > studies and not more recent data," said Genest, who is working on
>> > updating the guidelines to reflect research that suggests high-risk
>> > patients should be treated more aggressively.
>> >
>> > The study suggests people who are taking statins talk to their
>> doctors
>> > about what their real risk of heart attack is, and whether the drugs
>> > offer significant benefit in each case.
>> >
>> > They stress that statin therapy is appropriate for people at high
>> risk
>> > of heart attack, specifically those already diagnosed with heart
>> > disease.
>> >
>> > ******
>> >
>> > It is all a massive waste of money and peoples health to treat a
>> > non-issue like cholesterol with dangerous, expensive and ineffective
>> > drugs.
>> >
>> > A winfall for the pharmaceuticals that sponsored and engineered the
>> > establishment of these very low guidelines.
>> >
>> > TC
>>
>
.
- References:
- Prev by Date: U.S. plans a major reduction in its BSE testing
- Next by Date: Re: lectins and cancer
- Previous by thread: Re: doctors overprescribe costly cholesterol-lowering drugs for minimal benefits
- Next by thread: Re: doctors overprescribe costly cholesterol-lowering drugs for minimal benefits
- Index(es):
Relevant Pages
|